5Marx A, Schultz A, Wilisch A, et al. Myasthenia gravis. Verh Dtsch Ges Pathol, 1996,80 : 116 - 126. 被引量:1
6Henze T. Therapy of Myasthenia gravis with cholinesterase inhibitors-principles and pharmacologic monitoring. Fortscchr Neurol psychiatr,1996,64(3):110 - 121. 被引量:1
7Engel AG, Ohno K, Sine SM. Congenital Myasthenia syndrome recent advance. Arch Neurol, 1999,56(2) : 163 - 167. 被引量:1
9Drachman DB.Myasthenia gravis:immunology of a receptor disorder[J].Trends Neurosci,1983,6 (10):446-451. 被引量:1
10Anlar B,Senbil N,Kose G,et al.Serological follow-up in juvenile myasthenia:clinical and acetylcholine receptor antibody status of patients followed for at least 2 years[J].Neuromuscul Dis,2005,15 (5):355-357. 被引量:1